Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Guidance
28 févr. 2025 06h30 HE
|
Rapid Micro Biosystems, Inc.
Reports record fourth quarter 2024 total revenue of $8.2 million, representing 30% growth compared to fourth quarter 2023; recurring revenue increased by 27% compared to the fourth quarter of...
Rapid Micro Biosystems Announces Global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany
27 févr. 2025 16h15 HE
|
Rapid Micro Biosystems, Inc.
LEXINGTON, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company” or “Rapid Micro”), an innovative life sciences technology company providing mission...
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
26 févr. 2025 16h15 HE
|
Rapid Micro Biosystems, Inc.
LEXINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025
20 févr. 2025 16h30 HE
|
Rapid Micro Biosystems, Inc.
LEXINGTON, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation...
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenue
14 janv. 2025 16h15 HE
|
Rapid Micro Biosystems, Inc.
Fourth quarter 2024 total revenue expected to be a record at approximately $8.2 million, representing growth of approximately 30% compared to the prior-year period. Fourth quarter 2024 recurring...
Rapid Micro Biosystems to Present at 43ʳᵈ Annual J.P. Morgan Healthcare Conference
07 janv. 2025 16h05 HE
|
Rapid Micro Biosystems, Inc.
LEXINGTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Participate in the Stifel 2024 Healthcare Conference
08 nov. 2024 08h00 HE
|
Rapid Micro Biosystems, Inc.
LEXINGTON, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports Third Quarter 2024 Financial Results
01 nov. 2024 07h00 HE
|
Rapid Micro Biosystems, Inc.
Reports record third quarter 2024 revenue of $7.6 million, representing growth of 24% compared to the third quarter of 2023Placed seven Growth Direct® systems in the third quarter of 2024, marking the...
Rapid Micro Biosystems to Announce Third Quarter 2024 Financial Results on November 1, 2024
23 oct. 2024 16h45 HE
|
Rapid Micro Biosystems, Inc.
LEXINGTON, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation...
Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
03 sept. 2024 16h50 HE
|
Rapid Micro Biosystems, Inc.
LEXINGTON, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...